What is modulating solubility in simulated intestinal fluids?

被引：85
作者：
Ottaviani, Giorgio [1 ]
Gosling, Daniel J. [1 ]
Patissier, Celine [1 ]
Rodde, Stephane [1 ]
Zhou, Liping [2 ]
Faller, Bernard [1 ]
机构：
[1] Novartis Inst BioMed Res, Basel, Switzerland
[2] Novartis Inst BioMed Res, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2010年 / 41卷 / 3-4期
关键词：
Simulated intestinal fluids; Solubility; Ionization; Lipophilicity; Crystal packing; SOLUBLE WEAK BASES; DISSOLUTION MEDIA; DRUG; DELIVERY;
D O I：
10.1016/j.ejps.2010.07.012
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim of this study was to understand which parameters are responsible for the selective modulation of compounds solubility in simulated intestinal fluids. The solubility of 25 chemically diverse reference compounds was measured in simulated intestinal fluid (FaSSIF-V2) and in aqueous phosphate and maleate buffers. Electrostatic interactions between compounds and the bio-relevant medium components seem to explain the different solubility behavior observed for acids and bases. The solubility of ionized acids is not increased in FaSSIF-V2 probably due to electrostatic repulsions with the media components. Lipophilicity plays an important role but mainly for charged bases with a log P > 4 (or log D-6.5 > 1.9). When the aqueous solubility is mainly driven by lipophilicity, the FaSSIF-V2 components seem to improve the solubility of basic compounds to a greater extent than for compounds whose solubility is limited by crystal packing. These results suggest that ionization, lipophilicity and crystal packing play important but peculiar roles in controlling solubility in FaSSIF-V2 compared to that in aqueous buffer and this information could be useful to guide medicinal chemists and formulation scientists. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码：452 / 457
页数：6
相关论文
共 21 条
[1]   High throughput solubility measurement in drug discovery and development [J].
Alsenz, Jochem ;
Kansy, Manfred .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :546-567
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   Insertion and partition of sodium taurocholate into egg phosphatidylcholine vesicles [J].
Andrieux, K ;
Forte, L ;
Lesieur, S ;
Paternostre, M ;
Ollivon, M ;
Grabielle-Madelmont, C .
PHARMACEUTICAL RESEARCH, 2004, 21 (08) :1505-1516
[4]  
[Anonymous], HDB ESSENTIAL PHARMA
[5]   pH-metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods [J].
Avdeef, A ;
Berger, CM ;
Brownell, C .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :85-89
[6]  
Avdeef A., 2003, ABSORPTION DRUG DEV
[7]   High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media [J].
Bard, Bruno ;
Martel, Sophie ;
Carrupt, Pierre-Alain .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 33 (03) :230-240
[8]   Accuracy of calculated pH-dependent aqueous drug solubility [J].
Bergström, CAS ;
Luthman, K ;
Artursson, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (05) :387-398
[9]   Using Measured pKa, LogP and Solubility to Investigate Supersaturation and Predict BCS Class [J].
Box, K. J. ;
Comer, J. E. A. .
CURRENT DRUG METABOLISM, 2008, 9 (09) :869-878
[10]   Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability? [J].
Brouwers, Joachim ;
Brewster, Marcus E. ;
Augustijns, Patrick .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (08) :2549-2572
123